Particle therapy update
ANSTO physicist will gain further experience in particle therapy technologies.
Showing 781 - 800 of 1414 results
ANSTO physicist will gain further experience in particle therapy technologies.
Scientists have found a new approach to killing antibiotic-resistant bacteria using lipid nanoparticles that target specific layers on the surface of the bacterial cell.
Australia and Sri Lanka develop action plan to fight Chronic Kidney Disease killer
With more than thirty years of expertise and experience in critical minerals and rare earths extraction and processing, ANSTO welcomes the Australian Government’s announcement of a 2022 Critical Minerals Strategy
Following your experiment at ANSTO there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.
Snapshots of an unprecedented double element-hydrogen bond activation at a transition metal centre.
ANSTO conducts and enables research to address some of Australia’s and the world’s most challenging environmental problems.
ANSTO has a range of capabilities and expertise to support aerospace and space research.
Professor Helen Garnett is a senior science leader and experienced company director, with a distinguished record spanning national science infrastructure, research and university leadership.
Mr Michael Quigley is an experienced director, senior business executive and former engineer. He has extensive corporate, financial and governance experience across the public and private sectors.
Darren Mason is a senior business leader with over 30 years of experience in the nuclear, radiation, petrochemical, freight and energy sectors. He joined ANSTO in 2023 in a key role managing consultancy for calibration, training, nuclear waste and radi